About Interpace Biosciences
Interpace Biosciences is a company based in Parsippany Troy Hills (United States) founded in 1986.. The company has 94 employees as of February 28, 2023. Interpace Biosciences offers products and services including PancraGEN, ThyGeNEXT, and ThyraMIR. Interpace Biosciences operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Parsippany Troy Hills, United States
- Employees 94 as on 28 Feb, 2023
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Interpace Biosciences, Inc.
-
Annual Revenue
$46.93 M17as on Dec 31, 2024
-
Net Profit
$6.7 M0as on Dec 31, 2024
-
EBITDA
$8.11 M105as on Dec 31, 2024
-
Latest Funding Round
$47 M (USD), Post-IPO
Oct 11, 2024
-
Investors
1315 Capital
& 1 more
-
Employee Count
94
as on Feb 28, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Interpace Biosciences
Interpace Biosciences offers a comprehensive portfolio of products and services, including PancraGEN, ThyGeNEXT, and ThyraMIR. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assesses risk of pancreatic cyst cancer for early detection.
Evaluates thyroid nodules to guide treatment decisions.
Complements thyroid testing for improved accuracy in diagnostics.
Unlock access to complete
Funding Insights of Interpace Biosciences
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $47.0M
-
First Round
First Round
(20 Jan 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Post-IPO - Interpace Biosciences | Valuation |
investors |
|
| Jan, 2020 | Amount | Post-IPO - Interpace Biosciences | Valuation |
investors |
|
| Oct, 2017 | Amount | Post-IPO - Interpace Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Interpace Biosciences
Interpace Biosciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include 1315 Capital and Ampersand Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Expansion and growth capital is provided by 1315 Capital to healthcare companies.
|
Founded Year | Domain | Location | |
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Interpace Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Interpace Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Interpace Biosciences Comparisons
Competitors of Interpace Biosciences
Interpace Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Interpace Biosciences
Frequently Asked Questions about Interpace Biosciences
When was Interpace Biosciences founded?
Interpace Biosciences was founded in 1986 and raised its 1st funding round 31 years after it was founded.
Where is Interpace Biosciences located?
Interpace Biosciences is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.
Who is the current CEO of Interpace Biosciences?
Thomas Burnell is the current CEO of Interpace Biosciences.
How many employees does Interpace Biosciences have?
As of Feb 28, 2023, the latest employee count at Interpace Biosciences is 94.
What is the annual revenue of Interpace Biosciences?
Annual revenue of Interpace Biosciences is $46.93M as on Dec 31, 2024.
What does Interpace Biosciences do?
Founded in 1986 and headquartered in Parsippany Troy Hills, United States, operations in the healthcare sector are focused on molecular diagnostics for cancer. Evidence-based tests for early detection and treatment guidance are offered, along with pathology services. These solutions support clinical decision-making in oncology, with services delivered through a network addressing gastrointestinal, thyroid, and pancreatic cancers.
Who are the top competitors of Interpace Biosciences?
Interpace Biosciences's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Interpace Biosciences offer?
Interpace Biosciences offers PancraGEN, ThyGeNEXT, and ThyraMIR.
Who are Interpace Biosciences's investors?
Interpace Biosciences has 2 investors. Key investors include 1315 Capital, and Ampersand Capital Partners.